Skip to main content

NeuroScientific completes Isopogen acquisition

2 days ago

Bookmark

Save articles for future reference.

NeuroScientific has completed its acquisition of Perth pharmaceuticals company Isopogen WA, which controls the StemSmart technology patent, in a bid to boost its stem cell offerings.

X

To read our articles you will need to either login or subscribe.